Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Pharmacol.

Sec. Ethnopharmacology

Volume 16 - 2025 | doi: 10.3389/fphar.2025.1640358

This article is part of the Research TopicEnhancing Cancer Therapy: Integrating Plant-Derived Bioactives with Chemotherapy through Traditional Knowledge and Modern AdvancesView all 21 articles

Anticancer ethnomedicines in Taiwan

Provisionally accepted
Chien-Yu  KoChien-Yu Ko1Min-Han  ChiMin-Han Chi1Jung  ChaoJung Chao2*Shyh-Shyun  HuangShyh-Shyun Huang1*Hong-Zin  LeeHong-Zin Lee1*
  • 1School of Pharmacy, China Medical University (Taiwan), Taichung, Taiwan
  • 2Chinese Medicine Research Center, Department of Chinese Pharmaceutical Sciences and Chinese Medicine Resources, Master Program for Food and Drug Safety, China Medical University (Taiwan), Taichung, Taiwan

The final, formatted version of the article will be published soon.

Cancer remains a leading global health issue and has been the leading cause of death in Taiwan for over four decades. In recent years, ethnomedicines have gained growing attention as complementary therapies in cancer treatment. However, systematic investigations linking traditional medicinal practices with cancer remain limited. This study aims to explore the types, preparation methods, and parts used of anticancer ethnomedicines and cancer types across different regions in Taiwan through ethnobotanical surveys, and to preserve and transmit traditional knowledge. A total of 159 ethnomedicines were mentioned, with 146 plant species classified into 66 families, predominantly Asteraceae, Lamiaceae, and Fabaceae. The most commonly used plant parts were whole herba for herbaceous species, herba and radix for lianas, and leaves for trees and shrubs. Water decoction was the most frequently reported preparation method. The top ten mentioned ethnomedicines were traditionally used for a broader range of cancers than reported in the PubMed literature, especially for breast, lung, liver, and colorectal cancers, showing high consistency between traditional usage and modern scientific findings. Data were collected through questionnaire-based interviews with 210 participants, sampled proportionally by region, age, gender, and education based on national demographics. Chi-squared tests showed that only education level significantly influenced the number of anticancer ethnomedicines mentioned (p < 0.001), suggesting that Taiwan's policies promoting traditional medicine education may enhance knowledge retention. Consensus factor analysis revealed high agreement among respondents regarding remedies for the ten most common cancers in Taiwan, except for prostate and oral cancers, possibly due to clinical treatment limitations or low questionnaire response rate. Taiwan's cultural diversity, linguistic unity, and unique geographical environment facilitate the accurate and comprehensive collection of ethnomedicinal data, leading to more valuable research outcomes. In summary, the results of this study provide a valuable foundation for future anticancer research, serving as a priority focus for further investigation into the underlying mechanisms of anticancer activity. Moreover, this research supports the scientific development and potential drug discovery of ethnomedicines in modern cancer treatment, contributing to the integration of traditional knowledge with contemporary biomedical approaches.

Keywords: anticancer ethnomedicine, Asteraceae, Cancer, Taiwan, traditional medicine, questionnaire

Received: 03 Jun 2025; Accepted: 25 Aug 2025.

Copyright: © 2025 Ko, Chi, Chao, Huang and Lee. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence:
Jung Chao, Chinese Medicine Research Center, Department of Chinese Pharmaceutical Sciences and Chinese Medicine Resources, Master Program for Food and Drug Safety, China Medical University (Taiwan), Taichung, Taiwan
Shyh-Shyun Huang, School of Pharmacy, China Medical University (Taiwan), Taichung, Taiwan
Hong-Zin Lee, School of Pharmacy, China Medical University (Taiwan), Taichung, Taiwan

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.